Buy Cablivi (caplacizumab) Online

5.00 out of 5

  • DISEASE INDICATIONS: Acquired thrombotic thrombocytopenic purpura (aTTP)
  • MANUFACTURER: Ablynx NV
  • USAGE: Intravenous
  • MEDICINE APPROVED BY:
  • European Medical Agency (EMA)
  • Food and Drug Administration (FDA)
  • Health Canada
  • Therapeutic Goods Administration (TGA)
Cablivi, with the generic name caplacizumab, is a prescription medication used in the treatment of acquired thrombotic thrombocytopenic purpura (aTTP), a rare and life-threatening blood disorder.

$4,236.10
Select optionsThis product has multiple variants. The options may be chosen on the product page
Add to wishlist